ResearcherFlorida Agricultural and Mechanical UniversityActive in the last 2 years
Andriana Inkoom
Matched on OpenAlex author ID A5059347482. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2022: 2 papers · 2023: 2 papers · 2024: 1 paper
Papers 5
- Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic canc… Co-author DOI 10.1016/j.ejps.2024.106754↗
- Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. Co-author DOI 10.1186/s12885-023-10928-w↗
- Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. Co-author DOI 10.3390/ijms24054288↗
- Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer. First author DOI 10.1186/s12885-022-10449-y↗
- Application of modified gemcitabine-loaded solid lipid nanoparticle in the treatment of pancreatic cancer patient-derived xenograft model Co-author DOI 10.21203/rs.3.rs-1777458/v1↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nkafu Bechem Ndemazie · 5 shared papers, 2022–2024 · strength 0.88
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Raviteja Bulusu · 5 shared papers, 2022–2024 · strength 0.88
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Edward Agyare · 5 shared papers, 2022–2024 · strength 0.88
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Bo Han · 5 shared papers, 2022–2024 · strength 0.88
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Esther Frimpong · 5 shared papers, 2022–2024 · strength 0.88
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Jose Gilberto Trevino · 3 shared papers, 2022–2023 · strength 0.49
- Paper Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. DOI 10.1186/s12885-023-10928-w↗
- Paper Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for panc… DOI 10.1186/s12885-022-10449-y↗
- Paper Application of modified gemcitabine-loaded solid lipid nanoparticle in the treatment of pancreatic cancer patient-deriv… DOI 10.21203/rs.3.rs-1777458/v1↗
- Sherise Chantell Rogers · 2 shared papers, 2023–2024 · strength 0.40
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
- Joy C. Okoro · 2 shared papers, 2023–2024 · strength 0.40
- Paper Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-… DOI 10.1016/j.ejps.2024.106754↗
- Paper Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. DOI 10.3390/ijms24054288↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.